Dr. Anna Jen

lead a division to pursue the company’s mission of developing innovative biological and biomaterial based products for localized therapy in wounds

coordinate scientific, personnel, and business functions within her unit in order to promote R&D of new product candidates, moving promising projects from preclinical formulation into clinical “proof-of-concept” phase

manage the scientific and operational aspects of Kuros’ early-stage clinical project in wound healing

Tissue engineering

Protein formulation